ロード中...
Immunogenicity assay of the Leishmune(®) vaccine against canine visceral leishmaniasis in Brazil
Leishmune(®) is the industrialized version of the FML-saponin vaccine which has been shown to develop 92–95% protection in vaccinated dogs and 76–80% vaccine efficacy against field canine visceral leishmaniasis (CVL) in Brazil. Leishmune(®) has been proven to be safe and tolerable and a transmission...
保存先:
| 出版年: | Vaccine |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier Ltd.
2008
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7173152/ https://ncbi.nlm.nih.gov/pubmed/18675868 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.07.029 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|